CD40LG and atherosclerosis: OSEs are dominant targets of B-1 cell derived innate IgM antibodies in both humans and mice (16, 37, 38), and recent elegant work using E06-scFv transgenic mice targeting OxPL clearly demonstrates the potent anti-inflammatory effect of blocking the actions of OxPL in limiting atherosclerosis (5).